EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Diagnostic Accuracy of Fecal Elastase‐1 Test for Pancreatic Exocrine Insufficiency: A Systematic Review and Meta‐Analysis

Daniel de la Iglesia iD, Belén Agudo-Castillo iD, Marco Galego-Fernández iD, Alberto Rama-Fernández, J Enrique Domínguez-Muñoz

United European Gastroenterology Journal · 2025-10 · 13 (8) · 1571-1582

DOI: 10.1002/ueg2.70061 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift United European Gastroenterology Journal, online erschienen am 26.06.2025. Verfasst von Daniel de la Iglesia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Puerta de Hierro University Hospital, Health Research Institute of Puerta de Hierro-Segovia de Arana, …. Hauptthemen laut MEDLINE: Exocrine Pancreatic Insufficiency, Feces, Pancreatic Elastase. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pancreatic exocrine insufficiency (PEI) results from a reduction in pancreatic secretion of enzymes, leading to malabsorption of nutrients, intestinal symptoms, nutritional deficiencies and related comorbidities. The diagnosis of pancreatic exocrine insufficiency should be based on digestive tests, mainly the coefficient of fat absorption (CFA), based on the quantification of 72 h fecal fat excretion (FFE). However, this test is rarely performed in clinical practice. Fecal elastase‐1 (FE‐1) is a simple and widely used alternative. This meta‐analysis evaluates the diagnostic accuracy of fecal elastase‐1 for the diagnosis of PEI diagnosed by CFA or 72h‐FFE.

Methods

A systematic search of databases was performed to identify studies evaluating fecal elastase‐1 and CFA/FFE for the diagnosis of pancreatic exocrine insufficiency. Inclusion criteria required original studies with data on sensitivity, specificity and other diagnostic metrics. Two independent reviewers performed data extraction and quality assessment using the QUADAS‐2 tool. Pooled sensitivity, specificity, likelihood ratios and diagnostic odds ratio (DOR) were calculated and heterogeneity was assessed using I‐squared tests.

Results

Thirteen studies with 888 patients were included. Fecal elastase‐1 at a cut‐off of 200 μg/g showed a pooled sensitivity and specificity of 0.94 and 0.69, respectively, with a DOR of 35.27. Lowering the cut‐off to 100 μg/g improved specificity to 0.82 but decreased sensitivity to 0.88. Subgroup analyses showed different diagnostic performance in different clinical contexts, with higher sensitivity in cystic fibrosis (0.98) and higher specificity in chronic pancreatitis (0.81). The positive and negative predictive values are limited in situations with low and high probability of pancreatic exocrine insufficiency, respectively.

Conclusions

Fecal elastase‐1 is a sensitive and moderately specific diagnostic tool for pancreatic exocrine insufficiency and is suitable for initial screening in high‐risk populations. However, its moderate specificity requires careful interpretation in lower risk settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Exocrine Pancreatic InsufficiencyFecesPancreatic ElastaseHumansSensitivity and SpecificityPancreatic Function TestsBiomarkers

Stichwörter der Autor:innen

chronic pancreatitiscoefficient of fat absorptioncystic fibrosisdiagnostic accuracyfat absorptionfecal elastasefecal fat excretionmeta‐analysispancreatic exocrine insufficiencysystematic review

Substanzen

Pancreatic ElastaseBiomarkers

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Puerta de Hierro University Hospital, Health Research Institute of Puerta de Hierro-Segovia de Arana, Majadahonda, Spain.
  • Department of Gastroenterology and Hepatology, University Hospital of Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.

ORCID-Profile: Daniel de la Iglesia, Belén Agudo-Castillo, Marco Galego-Fernández

Zitieren

APA

de la Iglesia, D., Agudo-Castillo, B., Galego-Fernández, M., Rama-Fernández, A., & Domínguez-Muñoz, J. E. (2025). Diagnostic Accuracy of Fecal Elastase‐1 Test for Pancreatic Exocrine Insufficiency: A Systematic Review and Meta‐Analysis. United European Gastroenterology Journal, 13(8), 1571-1582. https://doi.org/10.1002/ueg2.70061

Vancouver

de la Iglesia D, Agudo-Castillo B, Galego-Fernández M, Rama-Fernández A, Domínguez-Muñoz JE. Diagnostic Accuracy of Fecal Elastase‐1 Test for Pancreatic Exocrine Insufficiency: A Systematic Review and Meta‐Analysis. United European Gastroenterology Journal. 2025;13(8):1571-1582. doi:10.1002/ueg2.70061

BibTeX
@article{delaIglesia2025,
  author = {de la Iglesia, Daniel and Agudo-Castillo, Belén and Galego-Fernández, Marco and Rama-Fernández, Alberto and Domínguez-Muñoz, J Enrique},
  title = {Diagnostic Accuracy of Fecal Elastase‐1 Test for Pancreatic Exocrine Insufficiency: A Systematic Review and Meta‐Analysis},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  volume = {13},
  number = {8},
  pages = {1571--1582},
  doi = {10.1002/ueg2.70061}
}
Kostenlos starten →